Related Experiment Video
Updated: Aug 20, 2026

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis
Published on: February 24, 2023
Melioidosis; the remarkable imitator: recent perspectives
Loveleena1, Rama Chaudhry, Benu Dhawan
1Department of Microbiology, All India Institute of Medical Sciences, New Delhi.
Abstract:
Melioidosis is an important public health problem in some regions of the world. It is endemic in South East Asia. The clinical spectrum of melioidosis is extremely broad, and melioidosis requires awareness on the part of the clinician and the existence of a laboratory capable of isolating and identifying Burkholderia pseudomallei, the etiological agent of melioidosis. Beta-lactams such as ceftazidime is currently the treatment of choice. There is no vaccine licensed for human use. There is an urgent need for rapid diagnostic techniques and effective treatments that are affordable in countries where the disease is endemic.
Insights
Melioidosis is a significant public health issue, particularly in Southeast Asia, caused by Burkholderia pseudomallei. Current treatments like ceftazidime are effective, but rapid diagnostics and affordable therapies are urgently needed.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Melioidosis poses a substantial public health challenge in endemic regions, notably Southeast Asia.
- The disease presents a wide spectrum of clinical manifestations, demanding high clinical suspicion.
- Accurate diagnosis relies on laboratory isolation and identification of Burkholderia pseudomallei.
Purpose of the Study:
- To highlight the critical aspects of melioidosis diagnosis and treatment.
- To emphasize the need for improved diagnostic and therapeutic strategies for melioidosis.
Main Methods:
- Literature review on melioidosis epidemiology, clinical presentation, and current management.
- Analysis of diagnostic requirements for Burkholderia pseudomallei.
- Evaluation of existing treatment options and identification of therapeutic gaps.
Main Results:
- Melioidosis is endemic in Southeast Asia with diverse clinical presentations.
- Ceftazidime is the current treatment of choice for melioidosis.
- No licensed vaccine is available for human use.
Conclusions:
- Effective melioidosis management requires clinical awareness and robust laboratory support.
- There is an urgent need for rapid, affordable diagnostic methods for melioidosis.
- Development of novel, cost-effective treatments for melioidosis is crucial for endemic areas.
Related Concept Videos
MALDI-TOF Mass Spectrometry
Rapid Identification of Pathogens
Modern Molecular Taxonomy

